Allogene Therapeutics (ALLO) Return on Invested Capital (2019 - 2020)
Allogene Therapeutics' (ALLO) quarterly Return on Invested Capital came in at 0.0% in Q3 2020, little changed year-on-year from 0.0% in Q4 2019, and up 18.25% quarter-over-quarter from 0.0% in Q2 2020.
Allogene Therapeutics (ALLO) Return on Invested Capital (2019 - 2020) Analysis & Trends
Allogene Therapeutics has disclosed Return on Invested Capital across 2 years of filings, most recently posting 0.0% for Q3 2020.
- Return on Invested Capital for Q3 2020 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2020 was 0.0% (changed 0.0% YoY), and the FY2024 annual result was 0.01%, changed N/A from the prior year.
- Return on Invested Capital came in at 0.0% for Q3 2020 at Allogene Therapeutics, up from 0.0% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q2 2019 to a low of 0.0% in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.01% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -0.01% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -0.01% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Allogene Therapeutics | 482.98 Mn | 482.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 0.00% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | 0.00% |